KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Omega Healthcare Investors (OHI) over the last 14 years, with Q4 2025 value amounting to $6.0 million.

  • Omega Healthcare Investors' Asset Writedowns and Impairment rose 24634.43% to $6.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $21.4 million, marking a year-over-year increase of 26440.2%. This contributed to the annual value of $22.6 million for FY2025, which is 512.36% down from last year.
  • As of Q4 2025, Omega Healthcare Investors' Asset Writedowns and Impairment stood at $6.0 million, which was up 24634.43% from -$3.9 million recorded in Q3 2025.
  • In the past 5 years, Omega Healthcare Investors' Asset Writedowns and Impairment ranged from a high of $47.4 million in Q4 2022 and a low of -$14.2 million during Q2 2024
  • Its 5-year average for Asset Writedowns and Impairment is $13.1 million, with a median of $8.1 million in 2022.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 101045.29% in 2023, then tumbled by 16712.13% in 2024.
  • Omega Healthcare Investors' Asset Writedowns and Impairment (Quarter) stood at $35.3 million in 2021, then skyrocketed by 34.47% to $47.4 million in 2022, then tumbled by 91.67% to $4.0 million in 2023, then crashed by 56.04% to $1.7 million in 2024, then skyrocketed by 246.34% to $6.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $6.0 million for Q4 2025, versus -$3.9 million for Q3 2025 and $14.2 million for Q2 2025.